Medline reported net sales of $7.8 billion in Q4 2025, a 14% increase year-over-year; net income was $180 million, a 37.7% decrease year-over-year.
Net sales for the fourth quarter of 2025 were $7.8 billion, an increase of 14.8% from $6.8 billion in the fourth quarter of 2024, with organic sales¹ growing by 14.4%. The growth was primarily driven by higher volume, with both the Medline brand and supply chain solutions business segments delivering strong growth.
Source:富途快讯 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Liquidity Crunch in Cryptocurrency Mining: Causes and Analysis of the Current Situation in 2026
-
3
What Is XPRT? An Analysis of the Core Token of the Persistence Ecosystem and Where to Trade It
-
4
In-Depth Analysis of the POM Token (POM): Meme Coin Characteristics, Mechanisms, and Market Performance
-
5
Donald Trump TRUMP (TRUMP) 2026 Outlook: Analysis of Price Trends and Key Influencing Factors
-
6
Federal Appeals Court Rejects Bid to Block Trump’s Mail Voting Restrictions
-
7
Microsoft It is up 3.02% today and is currently trading at $464.720
-
8
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
9
WASM: An In-Depth Look at WebAssembly Technology and a Guide to Trading Related Tokens ZKWASM and WASM AI
-
10
India’s Kerala Struggles to Care for Aging Population with Low Fertility Rate
Markets Today
Recommended Reading







